{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:15:53Z","timestamp":1791234953030,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.canlet.2005.05.009","type":"journal-article","created":{"date-parts":[[2005,6,30]],"date-time":"2005-06-30T12:05:14Z","timestamp":1120133114000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["PPAR-\u03b3 ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells"],"prefix":"10.1016","volume":"236","author":[{"given":"Nomel\u00ed P.","family":"N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaitian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary G.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2005.05.009_bib1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1471-4914(01)02100-1","article-title":"Prospects for prevention and treatment of cancer with selective PPARgamma modulators (SPARMs)","volume":"7","author":"Sporn","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2005.05.009_bib2","first-page":"2765","article-title":"Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists","volume":"24","author":"Lea","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2005.05.009_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1523-1747.2002.01861.x","article-title":"Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma","volume":"119","author":"M\u00f6ssner","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2005.05.009_bib4","first-page":"3344","article-title":"Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo","volume":"58","author":"Kubota","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.05.009_bib5","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptor g and retinoid acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.canlet.2005.05.009_bib6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0016-5085(98)70072-1","article-title":"Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells","volume":"115","author":"Brockman","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2005.05.009_bib7","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1074\/jbc.274.13.9116","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands are potent inhibitors of angiogenesis in vitro and in vivo","volume":"274","author":"Xin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2005.05.009_bib8","first-page":"631","article-title":"Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects","volume":"25","author":"Yoshizumi","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2005.05.009_bib9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/jpet.103.063438","article-title":"The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines","volume":"309","author":"Strakova","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.canlet.2005.05.009_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1023\/A:1006713000684","article-title":"Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors","volume":"17","author":"Pelayo","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2005.05.009_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/01635589709514610","article-title":"Tyrosine and phenylalanine restriction induces G0\/G1 cell cycle arrest in murine melanoma in vitro and in vivo","volume":"29","author":"Fu","year":"1997","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.canlet.2005.05.009_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0305-7372(03)00118-X","article-title":"Methionine dependency and cancer treatment","volume":"29","author":"Cellarier","year":"2003","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canlet.2005.05.009_bib13","first-page":"877","article-title":"Decreased tissue plasminogen activator and increased plasminogen activator inhibitors are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine","volume":"18","author":"Pelayo","year":"2001","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2005.05.009_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1207\/S15327914NC4501_8","article-title":"Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells","volume":"45","author":"Fu","year":"2003","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.canlet.2005.05.009_bib15","series-title":"Cancer Metastasis Related Genes","first-page":"2191","article-title":"Inhibition of invasion and metastasis during specific amino acid restriction associated with metastasis suppressor and other gene changes","author":"Meadows","year":"2002"},{"key":"10.1016\/j.canlet.2005.05.009_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00058152","article-title":"Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction","volume":"8","author":"Elstad","year":"1990","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2005.05.009_bib17","first-page":"759","article-title":"Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors","volume":"78","author":"Abdallah","year":"1987","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2005.05.009_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3835(85)90154-5","article-title":"Influence of supplemental ascorbate on the antitumor activity of 5-hydroxydopa, a purported cytotoxic metabolite","volume":"29","author":"Pierson","year":"1985","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2005.05.009_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00293983","article-title":"Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma","volume":"16","author":"Meadows","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2005.05.009_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/01635589609514427","article-title":"Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin","volume":"25","author":"Elstad","year":"1996","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.canlet.2005.05.009_bib21","first-page":"3056","article-title":"Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy","volume":"42","author":"Meadows","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2005.05.009_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ajcn\/51.2.188","article-title":"Tyrosine- and phenylalanine-restricted formula diet augments immunocompetence in healthy humans","volume":"51","author":"Norris","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.canlet.2005.05.009_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/bjc.1997.274","article-title":"Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation","volume":"75","author":"Poirson-Bichat","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2005.05.009_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1207\/S15327914NC422_2","article-title":"Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction","volume":"42","author":"Epner","year":"2002","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.canlet.2005.05.009_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1054\/plef.2001.0266","article-title":"Peroxisome proliferator-activated receptor- gamma expression in human malignant and normal brain, breast and prostate-derived cells","volume":"64","author":"Nwankwo","year":"2001","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.canlet.2005.05.009_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(00)81567-6","article-title":"PPARgamma in monocytes: less pain, any gain?","volume":"93","author":"Spiegelman","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2005.05.009_bib27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-\u03b3","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2005.05.009_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/excr.1993.1031","article-title":"Localization of basic fibroblast growth factor in bovine endothelial cells: Immunohistochemical and biochemical studies","volume":"204","author":"Yu","year":"1993","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2005.05.009_bib29","first-page":"24","article-title":"Southwest Oncology Group studies in hormone-refractory prostate cancer","volume":"23","author":"Hussain","year":"1996","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2005.05.009_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1040-8428(02)00080-X","article-title":"Malignant melanoma: current state of primary and adjuvant treatment","volume":"45","author":"Pawlik","year":"2003","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2005.05.009_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000077722","article-title":"Genes related to growth regulation, DNA repair and apoptosis in an oestrogen receptor-negative (MDA-231) versus an oestrogen receptor-positive (MCF-7) breast tumour cell line","volume":"25","author":"Skog","year":"2004","journal-title":"Tumour Biol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438350500488X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438350500488X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:26:44Z","timestamp":1759591604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438350500488X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S030438350500488X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2005.05.009","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR-\u03b3 ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2005.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}